Pentabromodiphenyl ether

Overview

The purpose of this Toxicological Review is to provide scientific support and rationale for the hazard and dose-response assessment in IRIS pertaining to chronic exposure to 2,2',4,4',5-pentabromodiphenyl ether. It is not intended to be a comprehensive treatise on the chemical or toxicological nature of 2,2',4,4',5-pentabromodiphenyl ether (BDE-99).

The majority of the available toxicological information on the pentabromodiphenyl ether homolog group (CAS No. 32534-81-9) relates to the pentabromodiphenyl congener BDE-99 (CASRN 60348-60-9). Toxicological information related to other congeners in the pentabromodiphenyl ether homolog group is also discussed. However, this health assessment does not deal with commercial mixtures of brominated diphenyl ether homologs containing pentabromodiphenyl ether as one of the constituents of commercial formulations. In addition to BDE-99, IRIS health assessments have also been prepared for three other polybrominated diphenyl ether congeners: tetraBDE-47, hexaBDE-153, and decaBDE-209. These four congeners are those for which toxicological studies suitable for dose-response assessments were available and are the ones most commonly found in the environment and human biological media.

Background

PBDEs are used as flame retardants in furniture foam, plastics for TV cabinets, consumer electronics, wire insulation, and backcoatings for draperies and upholstery. An assessment of the potential health effects of four individual congeners of polybrominated diphenyl ethers has been undertaken. This final assessment includes reference values for the noncancer effects (RfD and RfC) and a cancer assessment, where supported by available data, for the BDE-99 congener of polybrominated diphenyl ether.

History/Chronology

Date	Description
Dec 2006	EPA released an external release draft for public review and comment.
Feb 2007	EPA hosted an external peer review of the document.
Jun 2008	EPA released the final report and updated the IRIS Web site.

This document has been reviewed in accordance with U.S. Environmental Protection Agency policy and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use.

• U. S. EPA. Toxicological Review of 2,2',4,4',5-pentabromodiphenyl Ether (Final Report). ORD, NCEA, Washington, DC. EPA/635/R-07/006F, 2008 (PDF)  (128  pp, 1.3 MB, about PDF)

If you have a disability and the format of any material on our web pages interferes with your ability to access the information, please reach out to us using the Contact Us about IRIS form for assistance. To enable us to respond in a manner most helpful to you, please indicate the nature of the accessibility problem, the web address of the requested material, your preferred format in which you want to receive the material (electronic format (ASCII, etc.), standard print, large print, etc.), and your contact information.